471 related articles for article (PubMed ID: 16249494)
1. The effects of prostaglandin analogues on IOP in prostanoid FP-receptor-deficient mice.
Ota T; Aihara M; Narumiya S; Araie M
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4159-63. PubMed ID: 16249494
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin analogues and mouse intraocular pressure: effects of tafluprost, latanoprost, travoprost, and unoprostone, considering 24-hour variation.
Ota T; Murata H; Sugimoto E; Aihara M; Araie M
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2006-11. PubMed ID: 15914616
[TBL] [Abstract][Full Text] [Related]
3. Human trabecular meshwork cell responses induced by bimatoprost, travoprost, unoprostone, and other FP prostaglandin receptor agonist analogues.
Sharif NA; Kelly CR; Crider JY
Invest Ophthalmol Vis Sci; 2003 Feb; 44(2):715-21. PubMed ID: 12556403
[TBL] [Abstract][Full Text] [Related]
4. The effects of prostaglandin analogues on prostanoid EP1, EP2, and EP3 receptor-deficient mice.
Ota T; Aihara M; Saeki T; Narumiya S; Araie M
Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3395-9. PubMed ID: 16877408
[TBL] [Abstract][Full Text] [Related]
5. The IOP-lowering effects and mechanism of action of tafluprost in prostanoid receptor-deficient mice.
Ota T; Aihara M; Saeki T; Narumiya S; Araie M
Br J Ophthalmol; 2007 May; 91(5):673-6. PubMed ID: 17124244
[TBL] [Abstract][Full Text] [Related]
6. Effect of bimatoprost on intraocular pressure in prostaglandin FP receptor knockout mice.
Crowston JG; Lindsey JD; Morris CA; Wheeler L; Medeiros FA; Weinreb RN
Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4571-7. PubMed ID: 16303950
[TBL] [Abstract][Full Text] [Related]
7. Ocular hypotensive FP prostaglandin (PG) analogs: PG receptor subtype binding affinities and selectivities, and agonist potencies at FP and other PG receptors in cultured cells.
Sharif NA; Kelly CR; Crider JY; Williams GW; Xu SX
J Ocul Pharmacol Ther; 2003 Dec; 19(6):501-15. PubMed ID: 14733708
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin subtype-selective and non-selective IOP-lowering comparison in monkeys.
Gabelt BT; Hennes EA; Bendel MA; Constant CE; Okka M; Kaufman PL
J Ocul Pharmacol Ther; 2009 Feb; 25(1):1-8. PubMed ID: 19232013
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of action of bimatoprost, latanoprost, and travoprost in healthy subjects. A crossover study.
Lim KS; Nau CB; O'Byrne MM; Hodge DO; Toris CB; McLaren JW; Johnson DH
Ophthalmology; 2008 May; 115(5):790-795.e4. PubMed ID: 18452763
[TBL] [Abstract][Full Text] [Related]
10. Agonist activity of bimatoprost, travoprost, latanoprost, unoprostone isopropyl ester and other prostaglandin analogs at the cloned human ciliary body FP prostaglandin receptor.
Sharif NA; Kelly CR; Crider JY
J Ocul Pharmacol Ther; 2002 Aug; 18(4):313-24. PubMed ID: 12222762
[TBL] [Abstract][Full Text] [Related]
11. Additivity of bimatoprost or travoprost to latanoprost in glaucomatous monkey eyes.
Gagliuso DJ; Wang RF; Mittag TW; Podos SM
Arch Ophthalmol; 2004 Sep; 122(9):1342-7. PubMed ID: 15364714
[TBL] [Abstract][Full Text] [Related]
12. The effects of bimatoprost and unoprostone isopropyl on the intraocular pressure of normal cats.
Bartoe JT; Davidson HJ; Horton MT; Jung Y; Brightman AH
Vet Ophthalmol; 2005; 8(4):247-52. PubMed ID: 16008704
[TBL] [Abstract][Full Text] [Related]
13. The effect of latanoprost, bimatoprost, and travoprost on circadian variation of intraocular pressure in patients with open-angle glaucoma.
Yildirim N; Sahin A; Gultekin S
J Glaucoma; 2008; 17(1):36-9. PubMed ID: 18303382
[TBL] [Abstract][Full Text] [Related]
14. Real-time intracellular Ca2+ mobilization by travoprost acid, bimatoprost, unoprostone, and other analogs via endogenous mouse, rat, and cloned human FP prostaglandin receptors.
Kelly CR; Williams GW; Sharif NA
J Pharmacol Exp Ther; 2003 Jan; 304(1):238-45. PubMed ID: 12490597
[TBL] [Abstract][Full Text] [Related]
15. The Roles Played by FP/EP3 Receptors During Pressure-lowering in Mouse Eyes Mediated by a Dual FP/EP3 Receptor Agonist.
Yamagishi-Kimura R; Honjo M; Aihara M
Invest Ophthalmol Vis Sci; 2022 Feb; 63(2):24. PubMed ID: 35147658
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines.
Stewart WC; Konstas AG; Nelson LA; Kruft B
Ophthalmology; 2008 Jul; 115(7):1117-1122.e1. PubMed ID: 18082886
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the diurnal ocular hypotensive efficacy of travoprost and latanoprost over a 44-hour period in patients with elevated intraocular pressure.
Dubiner HB; Sircy MD; Landry T; Bergamini MV; Silver LH; Darell Turner F; Robertson S; Andrew RM; Weiner A; Przydryga J
Clin Ther; 2004 Jan; 26(1):84-91. PubMed ID: 14996520
[TBL] [Abstract][Full Text] [Related]
18. Blood-aqueous barrier changes after the use of prostaglandin analogues in patients with pseudophakia and aphakia: a 6-month randomized trial.
Arcieri ES; Santana A; Rocha FN; Guapo GL; Costa VP
Arch Ophthalmol; 2005 Feb; 123(2):186-92. PubMed ID: 15710814
[TBL] [Abstract][Full Text] [Related]
19. Travoprost compared with other prostaglandin analogues or timolol in patients with open-angle glaucoma or ocular hypertension: meta-analysis of randomized controlled trials.
Li N; Chen XM; Zhou Y; Wei ML; Yao X
Clin Exp Ophthalmol; 2006 Nov; 34(8):755-64. PubMed ID: 17073898
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of travoprost, latanoprost and bimatoprost on ocular circulation: a 6-month clinical trial.
Koz OG; Ozsoy A; Yarangumeli A; Kose SK; Kural G
Acta Ophthalmol Scand; 2007 Dec; 85(8):838-43. PubMed ID: 17680841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
